Your weekly roundup of the latest news from Drug Topics®.
After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR
Pfizer Inc. and Moderna Inc. have indicated that they are going to price their shots at between $110 and $130. The shots should still be free to individuals because of rules barring out-of-pocket costs for such vaccinations.
Odactra, a tablet for treating pediatric house dust mite-induced allergic rhinitis, has been approved by the US Food and Drug Administration for patients aged 12 to 17 years.
A new report unpacks some of the challenges that independent pharmacists may face in the years ahead.
The public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.
FDA Approves Second Formulation of Humira Biosimilar Cyltezo
May 1st 2024According to Michael Osso, president and chief executive officer of the Crohn’s & Colitis Foundation, “the flexibility of having multiple biosimilar formulations to choose from is important to support broader patient access to biologic medicine.”